Riskpilot← Back to searchSign inGet full accessEPIPROTECT AB
ABActiveOrg 5566598404TolvmannavägenManufacture of pharmaceutical preparations · NACE 2120Est. 20040 employees
Revenue 2025
SEK 4,9M
EBITDA margin
-132.1%
-117% vs 2024
Equity ratio
54.0%
Financial strength
Net profit 2025
SEK -6,6M
-1570% vs 2024
| Revenue | SEK 4,9M | — |
| EBITDA | SEK -6,5M | -117% |
| Net profit | SEK -6,6M | -1570% |
| Total assets | SEK 19M | +235% |
| Equity | SEK 10,2M | +405% |
| Employees | 0 | — |
Legal name
EPIPROTECT AB
Org number
5566598404
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
14 april 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall ha till föremål för sin verksamhet att bedriva handel med varor för hygien och vård och därmed jämförlig verksamhet.
Address
Tolvmannavägen
Phone
+4649415100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 4 888 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | −3 | −2 970 | −6 456 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −319 |
| EBIT | 0 | 0 | −3 | −2 970 | −6 775 |
| Net financials | — | — | 30 | 82 | 210 |
| Profit before tax | 0 | 0 | 27 | −388 | −6 565 |
| Tax | −0 | −0 | −3 | −5 | −0 |
| Net profit | 0 | 0 | 24 | −393 | −6 565 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 398 | 2 398 | 2 422 | 5 663 | 18 975 |
| Equity | 2 398 | 2 398 | 2 422 | 2 028 | 10 248 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 3 635 | 8 727 |
| Total debt | — | — | — | 3 635 | 8 727 |
EBITDA margin
-132.1%
This company
15.8%
Market median
-936% vs market
20212025
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
-64.1%
This company
18.4%
Market median
-448% vs market
20212025
Net profit margin
-134.3%
This company
8.1%
Market median
-1758% vs market
20212025
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20212025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EF Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
MM Chief Auditor | Chief Auditor | 2022 – 2023 |
RS Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
RJ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EPIPROTECT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Marika Sengoltz | Chief Auditor | 0 companies |
| Roger Sixten Kennerth Didrick | Chief Executive Officer | 0 companies |
| Rolf Jörgen Petersson | Chief Executive Officer | 0 companies |
| Egil Fredric Moe | Chief Executive Officer | 0 companies |
| Camilla Jenny Linnéa Hiljanen | Board of Directors | 0 companies |
| Preben Terp-Nielsen | Chairman | 0 companies |
| Lars Göran Karlsson | Deputy Board Member | 0 companies |
| Sune Terp-Nielsen | Board of Directors | 0 companies |